Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.

MLA

Martin, Brice, et al. “Preclinical Validation of a Novel Therapeutic Strategy for Choroid Plexus Carcinoma.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 357, May 2023, pp. 580–90. EBSCOhost, https://doi.org/10.1016/j.jconrel.2023.04.016.

APA

Martin, B., Garman, T., Laramee, M., Wang, A., Zhang, X., Beck, E., Wilson, K., Klumpp-Thomas, C., McKnight, C., Xu, X., Hagen, N., Holland, D., Dahmane, N., Thomas, C. J., & Souweidane, M. (2023). Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma. Journal of Controlled Release : Official Journal of the Controlled Release Society, 357, 580–590. https://doi.org/10.1016/j.jconrel.2023.04.016

Chicago

Martin, Brice, Tyler Garman, Madeline Laramee, Amy Wang, Xiaohu Zhang, Erin Beck, Kelli Wilson, et al. 2023. “Preclinical Validation of a Novel Therapeutic Strategy for Choroid Plexus Carcinoma.” Journal of Controlled Release : Official Journal of the Controlled Release Society 357 (May): 580–90. doi:10.1016/j.jconrel.2023.04.016.